Christopher Labos: Diet and exercise in a post-Ozempic world
If losing weight was easy, everyone would do it. Two recent studies raise difficult questions about behavioural interventions.
Medications like semaglutide (Ozempic, Wegovy) have changed how we talk about weight loss. Obesity was, and often still is, seen as a lifestyle problem rather than a chronic disease needing a chronic treatment. But in the frenzy surrounding the new-found popularity of this drug class, we still have a major unanswered question: What role do lifestyle interventions play in this new post-medication era? Read More